Publications
33 found
Show per page
Holze, F., Madsen, M. K., Svarer, C., Gillings, N., Stenbaek, D. S., Rudin, D., Duthaler, U., Liechti, M. E., Fisher, P. M., & Knudsen, G. M. (2024). Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research [Journal-article]. European Neuropsychopharmacology, 88, 43–48. https://doi.org/10.1016/j.euroneuro.2024.07.003
Holze, F., Madsen, M. K., Svarer, C., Gillings, N., Stenbaek, D. S., Rudin, D., Duthaler, U., Liechti, M. E., Fisher, P. M., & Knudsen, G. M. (2024). Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research [Journal-article]. European Neuropsychopharmacology, 88, 43–48. https://doi.org/10.1016/j.euroneuro.2024.07.003
Straumann, I., Avedisian, I., Klaiber, A., Varghese, N., Eckert, A., Rudin, D., Luethi, D., & Liechti, M. E. (2024). Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants [Journal-article]. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01972-6
Straumann, I., Avedisian, I., Klaiber, A., Varghese, N., Eckert, A., Rudin, D., Luethi, D., & Liechti, M. E. (2024). Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants [Journal-article]. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-01972-6
Arias, H. R., Micheli, L., Rudin, D., Bento, O., Borsdorf, S., Ciampi, C., Marin, P., Ponimaskin, E., Manetti, D., Romanelli, M. N., Ghelardini, C., Liechti, M. E., & Di Cesare Mannelli, L. (2024). Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation. Biomedicine and Pharmacotherapy, 177. https://doi.org/10.1016/j.biopha.2024.116867
Arias, H. R., Micheli, L., Rudin, D., Bento, O., Borsdorf, S., Ciampi, C., Marin, P., Ponimaskin, E., Manetti, D., Romanelli, M. N., Ghelardini, C., Liechti, M. E., & Di Cesare Mannelli, L. (2024). Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation. Biomedicine and Pharmacotherapy, 177. https://doi.org/10.1016/j.biopha.2024.116867
Anliker‐Ort, Marion, Rodieux, Frédérique, Ziesenitz, Victoria C., Atkinson, Andrew, Bielicki, Julia A., Erb, Thomas O., Gürtler, Nicolas, Holland‐Cunz, Stefan, Duthaler, Urs, The Journal of Clinical Pharmacology, 64(7), 810–819. https://doi.org/10.1002/jcph.2428
, Haschke, Manuel, van den Anker, John, Pfister, Marc, & Gotta, Verena. (2024). Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study [Journal-article].
Anliker‐Ort, Marion, Rodieux, Frédérique, Ziesenitz, Victoria C., Atkinson, Andrew, Bielicki, Julia A., Erb, Thomas O., Gürtler, Nicolas, Holland‐Cunz, Stefan, Duthaler, Urs, The Journal of Clinical Pharmacology, 64(7), 810–819. https://doi.org/10.1002/jcph.2428
, Haschke, Manuel, van den Anker, John, Pfister, Marc, & Gotta, Verena. (2024). Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study [Journal-article].
Thomann, Jan, Kolaczynska, Karolina E., Stoeckmann, Oliver V., Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1391689
, Vizeli, Patrick, Hoener, Marius C., Pryce, Christopher R., Vollenweider, Franz X., Liechti, Matthias E., & Duthaler, Urs. (2024). In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin [Journal-article].
Thomann, Jan, Kolaczynska, Karolina E., Stoeckmann, Oliver V., Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1391689
, Vizeli, Patrick, Hoener, Marius C., Pryce, Christopher R., Vollenweider, Franz X., Liechti, Matthias E., & Duthaler, Urs. (2024). In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin [Journal-article].
Anliker-Ort, Marion, Rodieux, Frédérique, Ziesenitz, Victoria C., Atkinson, Andrew, Bielicki, Julia A., Erb, Thomas O., Gürtler, Nicolas, Holland-Cunz, Stefan, Duthaler, Urs, Journal of Clinical Pharmacology, 64, 810–819. https://doi.org/10.1002/jcph.2428
, Haschke, Manuel, van den Anker, John, Pfister, Marc, & Gotta, Verena. (2024). Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study.
Anliker-Ort, Marion, Rodieux, Frédérique, Ziesenitz, Victoria C., Atkinson, Andrew, Bielicki, Julia A., Erb, Thomas O., Gürtler, Nicolas, Holland-Cunz, Stefan, Duthaler, Urs, Journal of Clinical Pharmacology, 64, 810–819. https://doi.org/10.1002/jcph.2428
, Haschke, Manuel, van den Anker, John, Pfister, Marc, & Gotta, Verena. (2024). Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study.
Arias, Hugo R., European Journal of Pharmacology, 966. https://doi.org/10.1016/j.ejphar.2024.176329
, Hines, Dustin J., Contreras, April, Gulsevin, Alican, Manetti, Dina, Anouar, Youssef, De Deurwaerdere, Philippe, Meiler, Jens, Romanelli, Maria Novella, Liechti, Matthias E., & Chagraoui, Abdeslam. (2024). The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT 2A receptor activation.
Arias, Hugo R., European Journal of Pharmacology, 966. https://doi.org/10.1016/j.ejphar.2024.176329
, Hines, Dustin J., Contreras, April, Gulsevin, Alican, Manetti, Dina, Anouar, Youssef, De Deurwaerdere, Philippe, Meiler, Jens, Romanelli, Maria Novella, Liechti, Matthias E., & Chagraoui, Abdeslam. (2024). The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT 2A receptor activation.
Luethi, Dino, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1238. https://doi.org/10.1016/j.jchromb.2024.124123
, Straumann, Isabelle, Thomann, Jan, Avedisian, Isidora, Liechti, Matthias E., & Duthaler, Urs. (2024). Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers.
Luethi, Dino, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1238. https://doi.org/10.1016/j.jchromb.2024.124123
, Straumann, Isabelle, Thomann, Jan, Avedisian, Isidora, Liechti, Matthias E., & Duthaler, Urs. (2024). Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers.
Thomann, Jan, Kolaczynska, Karolina E., Stoeckmann, Oliver V., Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1391689
, Vizeli, Patrick, Hoener, Marius C., Pryce, Christopher R., Vollenweider, Franz X., Liechti, Matthias E., & Duthaler, Urs. (2024). In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin.
Thomann, Jan, Kolaczynska, Karolina E., Stoeckmann, Oliver V., Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1391689
, Vizeli, Patrick, Hoener, Marius C., Pryce, Christopher R., Vollenweider, Franz X., Liechti, Matthias E., & Duthaler, Urs. (2024). In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin.
Frontiers in Psychiatry, 14, 1042440. https://doi.org/10.3389/fpsyt.2023.1042440
, Areesanan, Alexander, Liechti, Matthias E., & Gründemann, Carsten. (2023). Classic psychedelics do not affect T cell and monocyte immune responses.
Frontiers in Psychiatry, 14, 1042440. https://doi.org/10.3389/fpsyt.2023.1042440
, Areesanan, Alexander, Liechti, Matthias E., & Gründemann, Carsten. (2023). Classic psychedelics do not affect T cell and monocyte immune responses.
Vogt, Severin B., Ley, Laura, Erne, Livio, Straumann, Isabelle, Becker, Anna M., Klaiber, Aaron, Holze, Friederike, Vandersmissen, Anja, Mueller, Lorenz, Duthaler, Urs, Translational Psychiatry, 13. https://doi.org/10.1038/s41398-023-02477-4
, Luethi, Dino, Varghese, Nimmy, Eckert, Anne, & Liechti, Matthias E. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.
Vogt, Severin B., Ley, Laura, Erne, Livio, Straumann, Isabelle, Becker, Anna M., Klaiber, Aaron, Holze, Friederike, Vandersmissen, Anja, Mueller, Lorenz, Duthaler, Urs, Translational Psychiatry, 13. https://doi.org/10.1038/s41398-023-02477-4
, Luethi, Dino, Varghese, Nimmy, Eckert, Anne, & Liechti, Matthias E. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.
Luethi, Dino, Maier, Julian, Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-04210-1
, Szöllősi, Dániel, Angenoorth, Thomas J. F., Stankovic, Stevan, Schittmayer, Matthias, Burger, Isabella, Yang, Jae-Won, Jaentsch, Kathrin, Holy, Marion, Das, Anand Kant, Brameshuber, Mario, Camacho-Hernandez, Gisela Andrea, Casiraghi, Andrea, Newman, Amy Hauck, Kudlacek, Oliver, Birner-Gruenberger, Ruth, Stockner, Thomas, et al. (2022). Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux.
Luethi, Dino, Maier, Julian, Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-04210-1
, Szöllősi, Dániel, Angenoorth, Thomas J. F., Stankovic, Stevan, Schittmayer, Matthias, Burger, Isabella, Yang, Jae-Won, Jaentsch, Kathrin, Holy, Marion, Das, Anand Kant, Brameshuber, Mario, Camacho-Hernandez, Gisela Andrea, Casiraghi, Andrea, Newman, Amy Hauck, Kudlacek, Oliver, Birner-Gruenberger, Ruth, Stockner, Thomas, et al. (2022). Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux.
Neuropsychopharmacology, 47(4), 914–923. https://doi.org/10.1038/s41386-021-01221-0
, McCorvy, John D., Glatfelter, Grant C., Luethi, Dino, Szöllősi, Dániel, Ljubišić, Tea, Kavanagh, Pierce V., Dowling, Geraldine, Holy, Marion, Jaentsch, Kathrin, Walther, Donna, Brandt, Simon D., Stockner, Thomas, Baumann, Michael H., Halberstadt, Adam L., & Sitte, Harald H. (2022). (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice [Journal-article].
Neuropsychopharmacology, 47(4), 914–923. https://doi.org/10.1038/s41386-021-01221-0
, McCorvy, John D., Glatfelter, Grant C., Luethi, Dino, Szöllősi, Dániel, Ljubišić, Tea, Kavanagh, Pierce V., Dowling, Geraldine, Holy, Marion, Jaentsch, Kathrin, Walther, Donna, Brandt, Simon D., Stockner, Thomas, Baumann, Michael H., Halberstadt, Adam L., & Sitte, Harald H. (2022). (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice [Journal-article].
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 47(4), 914–923. https://doi.org/10.1038/s41386-021-01221-0
, McCorvy JD, Glatfelter GC, Luethi D, Szöllősi D, Ljubišić T, Kavanagh PV, Dowling G, Holy M, Jaentsch K, Walther D, Brandt SD, Stockner T, Baumann MH, Halberstadt AL, & Sitte HH. (2022). (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 47(4), 914–923. https://doi.org/10.1038/s41386-021-01221-0
, McCorvy JD, Glatfelter GC, Luethi D, Szöllősi D, Ljubišić T, Kavanagh PV, Dowling G, Holy M, Jaentsch K, Walther D, Brandt SD, Stockner T, Baumann MH, Halberstadt AL, & Sitte HH. (2022). (2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.
Camacho-Hernandez GA, Casiraghi A, RSC Medicinal Chemistry, 12(7), 1174–1186. https://doi.org/10.1039/d1md00072a
, Luethi D, Ku TC, Guthrie DA, Straniero V, Valoti E, Schütz GJ, Sitte HH, & Newman AH. (2021). Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram.
Camacho-Hernandez GA, Casiraghi A, RSC Medicinal Chemistry, 12(7), 1174–1186. https://doi.org/10.1039/d1md00072a
, Luethi D, Ku TC, Guthrie DA, Straniero V, Valoti E, Schütz GJ, Sitte HH, & Newman AH. (2021). Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram.
Maier J, Rauter L, Neuropharmacology, 190, 108570. https://doi.org/10.1016/j.neuropharm.2021.108570
, Niello M, Holy M, Schmid D, Wilson J, Blough BE, Gannon BM, Murnane KS, & Sitte HH. (2021). α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
Maier J, Rauter L, Neuropharmacology, 190, 108570. https://doi.org/10.1016/j.neuropharm.2021.108570
, Niello M, Holy M, Schmid D, Wilson J, Blough BE, Gannon BM, Murnane KS, & Sitte HH. (2021). α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
Camacho-Hernandez, Gisela Andrea, Casiraghi, Andrea, RSC Medicinal Chemistry, 12(7), 1174–1186. https://doi.org/10.1039/d1md00072a
, Luethi, Dino, Ku, Therese C., Guthrie, Daryl A., Straniero, Valentina, Valoti, Ermanno, Schütz, Gerhard J., Sitte, Harald H., & Newman, Amy Hauck. (2021). Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram [Journal-article].
Camacho-Hernandez, Gisela Andrea, Casiraghi, Andrea, RSC Medicinal Chemistry, 12(7), 1174–1186. https://doi.org/10.1039/d1md00072a
, Luethi, Dino, Ku, Therese C., Guthrie, Daryl A., Straniero, Valentina, Valoti, Ermanno, Schütz, Gerhard J., Sitte, Harald H., & Newman, Amy Hauck. (2021). Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram [Journal-article].
Maier J, Niello M, Handbook of Experimental Pharmacology, 266, 199–214. https://doi.org/10.1007/164_2021_469
, Daws LC, & Sitte HH. (2021). The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances.
Maier J, Niello M, Handbook of Experimental Pharmacology, 266, 199–214. https://doi.org/10.1007/164_2021_469
, Daws LC, & Sitte HH. (2021). The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances.
Experimental Neurology, 343, 113778. https://doi.org/10.1016/j.expneurol.2021.113778
, Liechti, Matthias E., & Luethi, Dino. (2021). Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics.
Experimental Neurology, 343, 113778. https://doi.org/10.1016/j.expneurol.2021.113778
, Liechti, Matthias E., & Luethi, Dino. (2021). Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics.
Cismaru AL, Genes, 11(11), 1–21. https://doi.org/10.3390/genes11111275
, Ibañez L, Liakoni E, Bonadies N, Kreutz R, Carvajal A, Lucena MI, Martin J, Sancho Ponce E, Molokhia M, Eriksson N, EuDAC Collaborators, Krähenbühl S, Largiadèr CR, Haschke M, Hallberg P, Wadelius M, & Amstutz U. (2020). Genome-wide association study of metamizole-induced agranulocytosis in european populations.
Cismaru AL, Genes, 11(11), 1–21. https://doi.org/10.3390/genes11111275
, Ibañez L, Liakoni E, Bonadies N, Kreutz R, Carvajal A, Lucena MI, Martin J, Sancho Ponce E, Molokhia M, Eriksson N, EuDAC Collaborators, Krähenbühl S, Largiadèr CR, Haschke M, Hallberg P, Wadelius M, & Amstutz U. (2020). Genome-wide association study of metamizole-induced agranulocytosis in european populations.
Cismaru AL, Grimm L, Frontiers in Genetics, 11, 951. https://doi.org/10.3389/fgene.2020.00951
, Ibañez L, Liakoni E, Bonadies N, Kreutz R, Hallberg P, Wadelius M, EuDAC Collaborators, Haschke M, Largiadèr CR, & Amstutz U. (2020). High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis.
Cismaru AL, Grimm L, Frontiers in Genetics, 11, 951. https://doi.org/10.3389/fgene.2020.00951
, Ibañez L, Liakoni E, Bonadies N, Kreutz R, Hallberg P, Wadelius M, EuDAC Collaborators, Haschke M, Largiadèr CR, & Amstutz U. (2020). High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis.
Cismaru, Anca Liliana, Grimm, Livia, Frontiers in Genetics, 11, 951. https://doi.org/10.3389/fgene.2020.00951
, Ibañez, Luisa, Liakoni, Evangelia, Bonadies, Nicolas, Kreutz, Reinhold, Hallberg, Pär, Wadelius, Mia, EuDAC Collaborators, Haschke, Manuel, Largiadèr, Carlo R, & Amstutz, Ursula. (2020). High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis.
Cismaru, Anca Liliana, Grimm, Livia, Frontiers in Genetics, 11, 951. https://doi.org/10.3389/fgene.2020.00951
, Ibañez, Luisa, Liakoni, Evangelia, Bonadies, Nicolas, Kreutz, Reinhold, Hallberg, Pär, Wadelius, Mia, EuDAC Collaborators, Haschke, Manuel, Largiadèr, Carlo R, & Amstutz, Ursula. (2020). High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis.
Cismaru, Anca Liliana, Genes, 11(11), 1275. https://doi.org/10.3390/genes11111275
, Ibañez, Luisa, Liakoni, Evangelia, Bonadies, Nicolas, Kreutz, Reinhold, Carvajal, Alfonso, Lucena, Maria Isabel, Martin, Javier, Sancho Ponce, Esther, Molokhia, Mariam, Eriksson, Niclas, EuDAC Collaborators, Krähenbühl, Stephan, Largiadèr, Carlo R, Haschke, Manuel, Hallberg, Pär, Wadelius, Mia, & Amstutz, Ursula. (2020). Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations.
Cismaru, Anca Liliana, Genes, 11(11), 1275. https://doi.org/10.3390/genes11111275
, Ibañez, Luisa, Liakoni, Evangelia, Bonadies, Nicolas, Kreutz, Reinhold, Carvajal, Alfonso, Lucena, Maria Isabel, Martin, Javier, Sancho Ponce, Esther, Molokhia, Mariam, Eriksson, Niclas, EuDAC Collaborators, Krähenbühl, Stephan, Largiadèr, Carlo R, Haschke, Manuel, Hallberg, Pär, Wadelius, Mia, & Amstutz, Ursula. (2020). Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations.
Biomedicines, 8(7), 212. https://doi.org/10.3390/biomedicines8070212
, Schmutz, Maurice, Roos, Noëmi Johanna, Bouitbir, Jamal, & Krähenbühl, Stephan. (2020). Reactive Metamizole Metabolites Enhance the Toxicity of Hemin on the ATP Pool in HL60 Cells by Inhibition of Glycolysis.
Biomedicines, 8(7), 212. https://doi.org/10.3390/biomedicines8070212
, Schmutz, Maurice, Roos, Noëmi Johanna, Bouitbir, Jamal, & Krähenbühl, Stephan. (2020). Reactive Metamizole Metabolites Enhance the Toxicity of Hemin on the ATP Pool in HL60 Cells by Inhibition of Glycolysis.
Toxicology, 426, 152254. https://doi.org/10.1016/j.tox.2019.152254
, Roos NJ, Duthaler U, & Krähenbühl S. (2019). Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes.
Toxicology, 426, 152254. https://doi.org/10.1016/j.tox.2019.152254
, Roos NJ, Duthaler U, & Krähenbühl S. (2019). Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes.
Luethi, Dino, Walter, Melanie, Zhou, Xun, Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00438
, Krähenbühl, Stephan, & Liechti, Matthias E. (2019). Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones [Journal-article].
Luethi, Dino, Walter, Melanie, Zhou, Xun, Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.00438
, Krähenbühl, Stephan, & Liechti, Matthias E. (2019). Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones [Journal-article].
Krisai P, Acute liver failure in a patient treated with metamizole (Patent No. SEP). 10(SEP), Article SEP. https://doi.org/10.3389/fphar.2019.00996
, Grünig D, Scherer K., Pichler W., Terracciano L., & Krähenbühl S. (2019).
Krisai P, Acute liver failure in a patient treated with metamizole (Patent No. SEP). 10(SEP), Article SEP. https://doi.org/10.3389/fphar.2019.00996
, Grünig D, Scherer K., Pichler W., Terracciano L., & Krähenbühl S. (2019).
Luethi, Dino, Walter, Melanie, Zhou, Xun, Frontiers in Pharmacology, 10, 438. https://doi.org/10.3389/fphar.2019.00438
, Krähenbühl, Stephan, & Liechti, Matthias E. (2019). Para; -Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones.
Luethi, Dino, Walter, Melanie, Zhou, Xun, Frontiers in Pharmacology, 10, 438. https://doi.org/10.3389/fphar.2019.00438
, Krähenbühl, Stephan, & Liechti, Matthias E. (2019). Para; -Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones.
Luethi D, Walter M, Zhou X, Frontiers in Pharmacology, 10, 438. https://doi.org/10.3389/fphar.2019.00438
, Krähenbühl S, & Liechti ME. (2019). Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones.
Luethi D, Walter M, Zhou X, Frontiers in Pharmacology, 10, 438. https://doi.org/10.3389/fphar.2019.00438
, Krähenbühl S, & Liechti ME. (2019). Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones.
Biochemical Pharmacology, 163, 345–356. https://doi.org/10.1016/j.bcp.2019.01.011
, Lanzilotto, Angelo, Bachmann, Fabio, Housecroft, Catherine E., Constable, Edwin C., Drewe, Jürgen, Haschke, Manuel, & Krähenbühl, Stephan. (2019). Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells.
Biochemical Pharmacology, 163, 345–356. https://doi.org/10.1016/j.bcp.2019.01.011
, Lanzilotto, Angelo, Bachmann, Fabio, Housecroft, Catherine E., Constable, Edwin C., Drewe, Jürgen, Haschke, Manuel, & Krähenbühl, Stephan. (2019). Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells.
European Journal of Internal Medicine, 68, 36–43. https://doi.org/10.1016/j.ejim.2019.07.029
, Spoendlin, Julia, Cismaru, Anca L., Liakoni, Evangelia, Bonadies, Nicolas, Amstutz, Ursula, Meier, Christoph R., Krähenbühl, Stephan, & Haschke, Manuel. (2019). Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
European Journal of Internal Medicine, 68, 36–43. https://doi.org/10.1016/j.ejim.2019.07.029
, Spoendlin, Julia, Cismaru, Anca L., Liakoni, Evangelia, Bonadies, Nicolas, Amstutz, Ursula, Meier, Christoph R., Krähenbühl, Stephan, & Haschke, Manuel. (2019). Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
European Journal of Internal Medicine, 68, 36–43. https://doi.org/10.1016/j.ejim.2019.07.029
, Spoendlin, Julia, Cismaru, Anca L, Liakoni, Evangelia, Bonadies, Nicolas, Amstutz, Ursula, Meier, Christoph R, Krähenbühl, Stephan, & Haschke, Manuel. (2019). Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
European Journal of Internal Medicine, 68, 36–43. https://doi.org/10.1016/j.ejim.2019.07.029
, Spoendlin, Julia, Cismaru, Anca L, Liakoni, Evangelia, Bonadies, Nicolas, Amstutz, Ursula, Meier, Christoph R, Krähenbühl, Stephan, & Haschke, Manuel. (2019). Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.
Bachmann, Fabio, Duthaler, Urs, European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 120, 172–180. https://doi.org/10.1016/j.ejps.2018.05.003
, Krähenbühl, Stephan, & Haschke, Manuel. (2018). N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole.
Bachmann, Fabio, Duthaler, Urs, European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 120, 172–180. https://doi.org/10.1016/j.ejps.2018.05.003
, Krähenbühl, Stephan, & Haschke, Manuel. (2018). N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole.